Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Vivoryon Therapeutics AG, DE0007921835

Vivoryon Therapeutics AG english

06.11.2019 - 15:33:04

Vivoryon Therapeutics AG english. Vivoryon Therapeutics AG, DE0007921835

1. Details of the person discharging managerial responsibilities / person closely associated a) NameTitle: Dr. First name: Dinnies Last name(s): von der Osten 2. Reason for the notification a) Position / statusPosition: Member of the administrative or supervisory body

b) AmendmentCorrection of the notification of 30 October 2019: Correction volume - due to an incorrect entry by the bank, the wrong number of shares was first used for the calculation. 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) NameVivoryon Therapeutics AG b) LEI3912004AMB0KGZXZYJ15  4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification codeType: Share ISIN: DE0007921835 b) Nature of the transactionAcquisition of shares by exercise of subscription rights c) Price(s) and volume(s)Price(s) Volume(s) 5.61 EUR 84150.00 EUR d) Aggregated informationPrice Aggregated volume 5.61 EUR 84150.00 EUR e) Date of the transaction2019-10-25; UTC+1 f) Place of the transactionOutside a trading venue

06.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Vivoryon Therapeutics AG Weinbergweg 22 06120 Halle/Saale

Germany Internet: www.vivoryon.com   End of News DGAP News Service

54729  06.11.2019 

@ dgap.de